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Abstract
The Effect of Compliance Changes on Delivered Tidal Volumes and Amplitude in an
Adult Patient Ventilated with High Frequency Oscillatory Ventilation: A Bench Model
By
John A. England
Clinical concerns exist regarding the delivered tidal volume (Vt) during highfrequency oscillatory ventilation (HFOV). HFOV is increasingly being used as a lung
protective mode of ventilation for patients with Adult Respiratory Distress Syndrome
(ARDS), but caution must be utilized. The purpose of this study was to investigate the
effect of airway compliance on Vt delivered by HFOV to the adult patient.
Method: An in vitro model was used to simulate an adult passive patient with ARDS,
using a high fidelity breathing simulator (ASL 5000, IngMar Medical). The simulation
included independent lung ventilation with a fixed resistance and adjustable compliance
for each lung. Compliances of 10, 15, 20 and 25 ml/cmH2O were used and resistance
(Raw) was fixed at 15 cm H2O/L/s. The ventilator SensorMedics 3100B (Cardinal
Health, Dublin, Ohio) was set to a fixed power setting of 6.0, insp-% of 33%, bias flow
=30 L/min, and 50% oxygen and Hz of 5.0 (n=5) for each compliance setting. Mean
airway pressure (mPaw) and amplitude (AMP) varied as the compliance changes were
made. Approximately 250 breaths were recorded at each compliance setting and the data
was collected via the host computer and transferred to a log to be analyzed by SPSS v.
10.
Data Analysis: The data analysis was performed using SPSS v. 10 to determine
the statistical significance of the delivered Vt with different compliances, different AMP
and a fixed power setting. A probability of (p < 0.05) was accepted as statistically
significant.
Results: The average delivered Vt with each compliance was 124.181 mL (range
of 116.4276 mL and 132.6637 mL) and average AMP of 84.85 cm/H2O (range 82.0
cm/H2O and 88.0801 cm/H2O) n=5. There was an inverse relationship between Vt and
AMP at a fixed power of 6.0. As compliance improved Vt increased and there was a
corresponding decrease in AMP. The one-way ANOVA test showed that there were
significant differences between the delivered tidal volume and AMP at a fixed power
setting. When the post hoc Bonferroni test was used the data showed significant
differences between AMP achieved with each compliance change and a fixed power of
6.0. When the post hoc Bonferroni test was used the data showed significant differences
between Vt delivered with each compliance change and a fixed power setting of 6.0.
Conclusion: Vt is not constant during HFOV. Compliance is one determinant of
Vt in adults with ARDS during HFOV. AMP and Vt are inversely related during HFOV
at a fixed power setting and improving compliance.
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Chapter I
Introduction
Historical Perspective
The field of respiratory care a relative new comer in the world of modern
medicine. In 1947 the predecessor of the present day American Association for
Respiratory Care (AARC) was chartered in the State of Illinois and called Inhalation
Therapy Association.

The role of the respiratory therapist has changed also from its

modest beginnings of setting up simple oxygen (O2) devices and cylinders in 1947 to
being recognized as healthcare professionals charged with the responsibility of
maintaining the 26 week gestational age, 500 gram neonate to the adult patient in
respiratory failure on conventional and non-conventional ventilation. Present day
therapists are considered experts in many areas but especially ventilator management.
They are also becoming actively involved in relevant and timely research.
High Frequency Oscillation Ventilation
One innovation in respiratory care is High Frequency Oscillatory Ventilation
(HFOV). HFOV is described as a ventilator that delivers a rate greater than 150 breaths
a minute. HFOV achieves gas transport with stroke volumes approximating anatomic
dead space and HFOV can be viewed as a mixing device that rapidly blends high O2/low
carbon dioxide (CO2) gas from the top of the endotracheal tube with gas in the alveoli.
Net transport occurs along the partial pressure gradients for O2 and CO2, with CO2
moving out of the lung along its partial gradient and O2 moving inward to the alveolar
capillary interface. These flow oscillations cause symmetric oscillations of
intrapulmonary pressure around a mean distending airway pressure (Tobin, 2006).
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According to the manufacturer, oxygenation and ventilation are considered
mutually exclusive. Oxygenation is achieved by the mean airway pressure (mPaw)
delivered by the oscillator or the FiO2. Ventilation is primarily determined by the stroke
volume of the device. Stroke volume is determined by the Delta-P of the frequency.
Figure 1 is a representation of the front panel of the 3100 B HFOV.
Mean

Amplitude (Delta-P)

Percent Inspiratory Time

Power Knob

Flow

Frequency (Hz)

Figure 1. Front Panel of the Model 3100B HFOV. Reprinted with permission by
Cardinal Health Inc. 2009
HFOV produces a waveform similar to a sine wave. The amplitude (AMP) of the
wave is determined by the power setting of the vent. The power setting also determines
the forward and backward motion of the piston which helps determine tidal volume.
Mean airway pressure is generated by a continuous flow of gas past a variable resistance
mushroom valve located on the expiratory limb of the patient’s circuit (Pilbeam & Cairo,
2006).
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A brief timeline of Premarket Approvals (PMA) is provided for FDA approval in
the use of HFOV in the adult patient with Adult Respiratory Distress Syndrome (ARDS).
3100 Approval

3/29/1991

3100A approval

9/15/1995

3100B approval

9/6/2001

Figure 2. Brief timeline of Premarket Approvals for HFOV
On March 29, 1991, a PMA was approved for the SensorMedic 3100 High
Frequency Oscillatory Ventilator (Cardinal Health, Dublin, Ohio) for the treatment of
neonates with respiratory failure and barotrauma. On September 15, 1995, a PMA
supplement was issued expanding the indications for use of the Model 3100A to include
certain pediatric patients who were failing conventional ventilation. On September 6,
2001 the FDA approved a PMA for the use of the Model 3100B for the ventilatory
support and treatment of selected patients 35 kilograms or greater in acute respiratory
failure (Summary, p890057s, p7).
Figure 3 is an introduction to the major gas transport mechanisms under
physiologic conditions during HFOV. The major mechanisms of gas transport and
exchange include: Taylor Dispersion, gas on inspiration will travel down the center of
the airway and expired gas will travel along the walls of the airway, Pendeluft movement
of gas, because of the differences in compliance and resistance lung areas flow will go to
the areas of the lunge with the greatest compliance and least resistance. There is also a
component bulk movement of gas similar to conventional ventilation.
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The major gas-transport mechanisms that are operative under physiologic conditions in
each region (convection, convection and diffusion, and diffusion alone) are shown in
figure 3. There are seven potential mechanisms that can enhance gas transport during
high-frequency ventilation: turbulence in the large airways, causing enhanced mixing;
direct ventilation of close alveoli; turbulent flow with lateral convective mixing;
pendelluft (asynchronous flow among alveoli due to asymmetries in airflow impedance);
gas mixing due to velocity profiles that are axially asymmetric (leading to the streaming
of "fresh" gas toward the alveoli along the inner wall of the airway and the streaming of
"alveolar" gas away from the alveoli along the outer wall); laminar flow with lateral
transport by diffusion (Taylor dispersion); and collateral ventilation through nonairway
connections between neighboring alveoli (Slutsky & Drazen, 2002).

Figure 3. Gas-Transport Mechanisms during High-Frequency Ventilation Slutsky A and
Drazen J. N Engl J Med 2002; 347:630-631 reprinted with permission by The New
England Journal of Medicine 2009
Fan and Stewart’s (2000) article supported the use of lower tidal volumes to
prevent lung injury and lower the incidence of mortality and reduce the number of
conventional ventilatory days. This technique has been used since 2001 for the
treatment of ARDS in the adult ICU population. The benefits of HFOV in the adult
patient is supported by the ARDSNet protocol of using small tidal volumes to ventilate a
patient with the clinical result of less barotrauma to the patient (Fan & Stewart, 2006).

5
Statement of problem

Clinical practitioners have consistently observed that over the first forty-eight to
seventy-two hours of initiating the use of HFOV in the adult patient the mPaw and the
AMP will spontaneously drop. This will happen without any intervention on the part of
the clinicians taking care of the patient. The power setting (driving the AMP) and the
flow will remain as originally set. Currently, the reason for this decrease in pressure is
not known; therefore, the purpose of this bench study is to determine if improvement in
the patient’s compliance results in a change in the volume delivered with each stroke of
the piston.

This is important from a clinician’s perspective. If you increase the driving
pressure to its original setting and the tidal volume increases, then are you putting the
patient at higher risk of developing barotrauma, lung damage including a pneumothorax
because of the increased tidal volume? From a retrospective chart review of the
management of patients on HFOV at a local area hospital, it was learned that patients
who had their AMP and mPaw returned to the original settings suffered a larger number
of pneumothoraces than patients that were not returned to their original setting. This led
to the following research question: Is there a direct correlation with the AMP and Vt
changing while on HFOV and the tidal volume delivered to the test lung? By knowing
the answer to this question the therapist will be able to provide safer care to the patient.
The realization that the patient’s lung compliance is changing for the better, the therapist
will not return the ventilator to its original settings, thus preventing a possible
pneumothorax by delivering a larger volume then needed. This could lead to
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transitioning back to conventional ventilation sooner and possibly a shorter ICU stay for
the patient. This could possibly reduce the total cost of the patient’s hospital stay. A
shorter hospital stay reduces the patient’s risk of a nosocomial infection which is a
complication of hospital care.

This chapter describes the role of the respiratory therapist in one aspect of critical
care: the management of HFOV and the importance of an astute respiratory therapist with
the understanding of how HFOV is assumed to work and the relevance of the values
reported on the oscillator. The understanding of the relationship of Vt and lung
compliance to the spontaneous drop in AMP will provide safer environment for the
patient.

Chapter II
Review of the Literature
Introduction
This literature review will cover the topics of HFOV as it relates to its uses and
benefits to the adult patient. Sources cited come from a variety of scholarly medical
journals using CINAHL Plus with Full Text: Nursing and Allied Health (at
EBSCOhost), MEDLINE with full text (at EBSCOhost) and PubMed databases. The
reviews were collected using the terms high frequency oscillatory ventilation and
compliance changes using HFOV as it pertains to the adult patient. Very few articles
pertaining to HFOV and the adult patient were found. This review is reflective of
current ventilatory strategies utilizing HFOV.
Indications for HFOV
There are few articles that describe the indications for HFOV in the adult patient;
five of these articles are summarized for this review.
Cartotto et al. (2005) article “studied 25 burn patients with 24 of them meeting the
criteria for ARDS”. ARDS has an acute onset and occurs from a loss of surfactant due
to the leakage of proteinaceous fluid into the pulmonary interstitium and alveoli causing
a loss of surfactant reducing the compliance in the lungs. There is a heterogeneous
appearance on a chest X-ray. Pulmonary artery pressure will usually be less than 18
mmHg, if the patient does not have a pulmonary arterial catheter in place the patient will
not be showing signs of left heart failure. The patients in Cartotto’s study had a
PaO2/FiO2 (PF) ratio of 98 ± 26. A PF ratio of ≤ 300mmHg is by definition Acute Lung
7
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Injury (ALI) and a PF ratio of ≤ 200 is considered ARDS. Oxygen index (OI) (FiO2 X
MAP X 100/PaO2) of 27 ± 10 just prior to initiating HFOV. Six of the patients were
receiving inhaled nitric oxide (iNO) at a level of 16 ± 6 ppm. Within one hour there was
a sustained increase in the P/F ratio and within 48 hours a continual decrease in the OI.
All of the patients receiving iNO were weaned off within 24 hours of starting HFOV.
HFOV was maintained for 6.1 ± 5.8 days (range of 2 hrs to 26 days). Seven patients
died, their underlying cause was sepsis with multiple organ failure. The 18 survivors
were converted back to controlled mandatory ventilation at a FiO2 of .40 ± 0.1 and a
mPaw of 24.4 ± 4.0 cm H2O.
Chan et al. (2005) wrote a literature review from articles written between 1980 to
2004 on HFOV. Chan reviewed eight clinical trials of various methodological designs.
All of these studies showed that HFOV lead to an improvement in oxygenation. Chan
also reported that refractory oxygenation can improve with the utilization of HFOV and
iNO. He concluded that HFOV can be a safe and effective mode of ventilation in the
adult patient with ARDS. Earlier intervention of HFOV is a recommendation of his
literature review.
Imai et al.’s (2005) article reviewed several studies using small animal models
and the effects of HFOV on lung damage. The animals had lung damage induced by lung
lavage to cause a low surfactant state. It was concluded in this article that HFOV can
reduce ventilator induced lung injury (VILI) compared with conventional ventilator
strategies. However, early neonatal studies did not support this conclusion (The HIFI
study Group, 1989). The use of lung recruitment measures in the neonate did show an
overall improvement in gas exchange. The author concluded that there is convincing
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animal data supporting the use of lung protective strategies such as HFOV in the adult patient.
Venegas et al. (1991) concluded that as tidal volume increases, gas transport changes
from inefficient dispersion to more efficient bulk movement of gas, with regional tidal volume to
dead space ratios. These findings are consistent with other large animal studies. This review
showed that gas exchange mechanisms during HFOV are accomplished by laminar flow,
turbulent dispersions, mixing due to asymmetrical velocity profiles, and pendelluft breathing.
These results were accomplished by using large animal experimentation.
Bollen et al. (2005) compared the safety and efficacy of HFOV with conventional
ventilation (CV) for early intervention of adult respiratory distress syndrome (ARDS). A
randomized trial in four intensive care units was conducted. The patients were randomized to
receive either conventional ventilation or HFOV. The trial was stopped early because of a low
inclusion rate (61 patients) and the completion of another trial comparing HFOV and
conventional ventilation but did conclude that in patients with ARDS with higher baseline OI
might benefit from HFOV.
Mechanism of HFOV
The mechanism of how HFOV works is not fully understood. The following articles will
discuss some of the most current ideas.
Pillow’s (2005) article collected data from studies indexed in PubMed illustrating key
concepts relevant to pressure transmission in the adult lung using a published theoretical model.
The article reviewed the mechanisms of gas exchange and transport during HFOV. Gas
transport during HFOV is accomplished through bulk movement of gas, diffusion, convection,
pendelluft and cardiac mixing and the roles they play in gas exchange. The article also
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introduced the bifurcation phenomenon and how gas streams fresh gas towards the alveoli along
the inner airways while “alveolar” gas is streamed away from the alveoli along the outer wall.
This phenomenon plays an important role in the longitudinal convective transport
mechanism during HFOV. The author concluded that the clinician needs to be aware that
HFOV adds a complexity that conventional ventilation lacks. The changes in compliance and
resistance of the patient and how these will influence clinical decisions at different frequencies,
flow and pressure transmitted to the lung must be understood. Clinicians must understand how
drops in mean airway pressure across the endotracheal tube could be altered by changing the
frequency, internal diameter of the endotracheal tube, and ventilator amplitude.
Carney et al. (2005) reviewed original published articles and review papers dealing with
the mechanism of lung volume changes at the alveolar level. The authors explain that it has
been suggested that the lung volumes change by alveolar recruitment and derecruitment. This
postulate suggests that the alveolus do not change size during ventilation. Smaldone et al.
(1983) demonstrated in their in vivo studies that the normal lung changes volume by alveolar
recruitment and derecruitment. The author also stated that data from their own laboratory
suggests that normal alveoli do not change size during ventilation. Also, they found that large
changes in alveolar size and widespread alveolar recruitment and derecruitment appear
dominant in acute lung injury. Tremblay et al. (1997) demonstrated that ventilating normal
excised lungs with very high inspiratory pressure and low positive end expiratory pressure
(PEEP) caused injury demonstrated by the release of inflammatory cytokines. Carney et al.
(2005) also states that unstable alveoli that open and close with each breath can cause a
significant shear stress lung injury. This study concluded that ventilator maneuvers that
stabilize the alveolus such as PEEP and HFOV may help to reduce the incidence of VILI.
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Other Uses of HFOV
Cartotto et al.’s (2005) article suggests a way that his team transported burn
patients to the operating room (OR). It consisted of clamping the patient’s ET tube to
maintain FRC and switching to a manual resuscitator with 20 cm H2O PEEP. During the
transport the patient would then be given quick small breaths with a resuscitation bag.
Prior to reinitiating HFOV in the OR, a recruitment maneuver would be performed and
oscillation then would be started. Cartotto’s team has transported 18 patients requiring
surgery to the OR. His conclusion is that HFOV was useful in the transporting of burn
patients with ARDS. The author suggests that further randomized clinical trials are
needed to assess the usefulness of HFOV.
This review of the preceding three categories: indications for HFOV, mechanism
of HFOV and other uses demonstrates the general lack of published clinical guidance for
the bedside clinician as it pertains to HFOV. More research is needed to fully understand
HFOV, and to give guidance to the bedside clinician. The purpose of my study was to
help the clinician to better understand the relationship between changing lung compliance
and delivered tidal volumes in the use of HFOV.

Chapter III
RESEARCH METHODS
Lung Model
An in vitro model was used to simulate the adult patient with ARDS using a high
fidelity breathing simulator (Active Servo Lung (ASL) 5000, Ingmar Medical, Pittsburgh,
PA, USA) to answer the following question: does changing lung compliance change the
volume delivered to a patient on HFOV. The ASL 5000 is digitally controlled, and is
piston-driven simulating real time breathing.
Ventilator Settings
The SensorMedics 3100B ventilator was used with a standard HFOV adult circuit
and a cuffed endotracheal tube size 8.0 mm internal diameter (I.D.) (Portex). The 3100B
HFOV parameters were set for an adult patient with ARDS according to Fessler et al.,
(2007) guidelines. Fessler et al., (2007) recommended the guidelines to optimize the lung
protective characteristics of HFOV. The 3100B ventilator was set at a power of 6, 33%
inspiratory time (Ti), frequency (f) of 5 Hz, mPaw varied to reflect the compliance that
was set on the ASL 5000, bias flow (BF) of 30 L/min and 50% oxygen.
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Protocol
To simulate an adult patient with severe ARDS on HFOV the ASL 5000 scenario of
an adult passive patient with changeable compliance and fixed resistance (Raw) for each
lung was varied at the following settings; the resistance was set during the experiment at
15cm H2O/L/s and the compliance was 10, 15, 20 and 25 mL/cm H2O (Protocol is
included in Appendix A).
The 3100B ventilator circuit was calibrated then set to the previous mentioned
settings. The ASL 5000 was connected to the ventilator (Figure 4) with a standard highfrequency breathing circuit and size 8.0 mm I.D. cuffed ETT. The ASL 5000 was
connected to the software host computer via Ethernet cable. Vt and total delivered
number of breaths were measured inside the test lung and recorded by the software host
computer.
Test Lung

ET Tube

Piston

HFOV

Cable

Computer

Figure 4. Schematic drawing of the experiment set-up
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Data Collection
Vt was measured and recorded five times (n = 5) for each level of compliance.
The measuring was done by ASL 5000 software at the same ventilator settings.
Approximately 250 breaths of data for each level of compliance was captured via the
ASL software and the volume of the 250th breath was recorded to be used in the analysis.
The number of breaths (250) was determined graphically; this is where the volume
delivered to the lung to plateau. This value is felt to be more reflective of what happens
physiologically in the lung then taking an average of the 250 breaths, because the drop in
AMP happens once a steady state is reached in the lung. By reviewing the captured data
Vt and amplitude was recorded and analyzed.
Data Analysis: The data analysis was performed using SPSS v. 16 one way
ANOVA, post hoc Bonferroni, descriptive statistics, Post hoc comparison and Pearson
correlation test to determine the statistical significance of the delivered Vt and AMP
measurements with different compliance settings. A probability of (p < 0.05) was
accepted as statistically significant.
In summary, this chapter described the methods used to investigate the
relationship between changing lung compliance and delivered tidal volumes in the use of
HFOV. Data was collected using the 3100B connected to a simulator and analyzed using
SPSS v.16.

Chapter IV
Results
The data outlined in this chapter are provided to assist in answering the following
question: is there an effect on volumes delivered in an adult patient ventilated with
HFOV as lung compliance change. For each trial an average of 250 breaths were
delivered by the 3100 B ventilator, the power was fixed at 6.0, the flow was set at 30 lpm
and the Hz was set at 5.0. The following tables reflect the statistical analysis for the
change in volume as the compliance is varied:
Tidal Volume as it Relates to Compliance
Table 2 reflects the descriptive statistical analysis of the four compliance settings
as compared to the volume delivered. The mean volumes increase as the compliance
improves and the power driving the piston remains constant.
Table 1. Descriptive Statistics volume compared to compliance change
Compliance

n

Mean

10 mL/cmH2O

5

117.6380

0.97482

116.36

118.87

15 mL/cmH20

5

121.7260

1.46290

119.64

123.42

20 mL/cmH2O

5

125.2420

1.49224

123.58

126.99

25 mL/cmH2O

5

132.1180

0.43951

131.68

132.85

20

124.1810

5.55754

116.36

132.85

Total

Std. Deviation Minimum Maximum

15

16

The one way ANOVA (Table 3) test showed that there was a significant
difference between delivered tidal volumes and improving compliance at a fixed power
setting.
Table 2. Anova table comparing volumes between groups

Mean Square
Between Groups 188.266
Within Groups 1.378

F
136.665

Sig.
0.000
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When the post hoc Bonferroni test (Table 4) was run, it showed specifically that
as each level of compliance was manipulated the tidal volume was directly related to it.
These measurements were performed at a power setting of 6.0.
Table 3. Multiple Comparisons Dependent Variable: Volume Bonferroni Analysis

Mean Difference (I-J)

Std. Error

Sig. 95% Confidence

Interval
(I) Compliance (J) Compliance
10

15

20

25

___________

15

-4.08800

0.74231

0.00*

20

-7.60400

0.74231

0.00*

25

-14.48000

0.74231

0.00*

10

4.08800

0.74231

0.00*

20

-3.51600

0.74231

0.00*

25

-10.39200

0.74231

0.00*

10

7.60400

0.74231

0.00*

15

3.51600

0.74231

0.00*

20

-6.87600

0.74231

0.00*

10

14.48000

0.74231

0.00*

15

10.39200

0.74231

0.00*

20

6.87600

0.74231

0.00*

Compliance = mL/cmH2O
* The mean difference is significant at the 0.05 level.

18
Amplitude as it Relates to Compliance

For each trial an average of 250 breaths was delivered by the 3100 B ventilator,
the power was fixed at 6.0, the flow was set at 30 lpm and the Hz was set at 5.0. The
following table reflects the descriptive statistics for the change in amplitude as the
compliance is varied. An average of 250 breaths was used as the target number of
breaths, because this was reflective of a steady state tidal volume delivered by the
ventilator, as reflected by the reading on the simulator.
Table 5 reflects the descriptive statistical analysis of the four compliance settings
as compared to the measured amplitude. The mean amplitude decreases as the
compliance improves and the power driving the piston remains constant.
Table 4. Descriptive Statistics amplitude to compliance change
n

Mean

10 mL/cmH2O

5

87.4000

0.54772

87.00

88.00

15 mL/cmH20

5

86.0000

0.00000

86.00

86.00

20 mL/cmH2O

5

84.0000

0.00000

84.00

84.00

25 mL/cmH2O

5

82.0000

0.00000

82.00

82.00

Total

20

2.10950

82.00

88.00

84.8500

Std. Deviation Minimum Maximum
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The one way ANOVA test (Table 6) showed that there was a significant
difference between measured amplitude and improving compliance at a fixed power
setting.
Table 5. Anova table comparing amplitude between groups
Mean Square
Between Groups

27.783

Within Groups

0.075

F
370.444

Sig.
0.00

20
When the post hoc Bonferroni test (Table 7) was performed, it showed
specifically as each level of compliance was manipulated the amplitude was directly
related to it. These measurements were all conducted at a power setting of 6.0.
Table 6. Multiple Comparisons Dependent Variable: Amplitude Bonferroni Analysis
Mean Difference (I-J)

Std. Error

Sig. 95% Confidence Interval

(I) Compliance (J) Compliance
10

15

20

25

15

1.40000

0.17321

0.000*

20

3.40000

0.17321

0.000*

25

5.40000

0.17321

0.000*

10

-1.40000

0.17321

0.000*

20

2.00000

0.17321

0.000*

25

4.00000

0.17321

0.000*

10

-3.40000

0.17321

0.000*

15

-2.00000

0.17321

0.000*

25

2.00000

0.17321

0.000*

10

-5.40000

0.17321

0.000*

15

-4.00000

0.17321

0.000*

20

- 2.00000

0.17321

0.000*

Compliance = mL/cmH2O
*The mean difference is significant at the 0.05 level.
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When Pearson correlation was performed, it showed a significant inverse
correlation between amplitude and tidal volume. These measurements were all
conducted at a power setting of 6.0.

Table 7: Pearson Correlation between Amplitude and Tidal Volume
Correlations
VOL

AMPS
-.969

Pearson
Correlation
Sig.
.000
N
20
** Correlation is significant at the 0.01

VOL
1
.
20

In summary the research question was answered; the spontaneous reduction of
amplitude is indicative of improving compliance. As also shown by this study it is an
inverse relationship. As amplitude decreased, tidal volume increased. Therefore,
clinicians caring for the patient should be aware of possible physiologic changes to the
patient.

Chapter V
Discussion
This chapter is a discussion of how lung compliance changes effect delivered tidal
volume during HFOV. According to this study during HFOV as lung compliance
improves, AMP will drop and Vt will increase. With this knowledge clinicians can treat
their patients safer by decreasing length of stay on a ventilator.
In clinical practice it has been observed that the amplitude and mean airway
pressure will decrease, as measured by the ventilator, usually within the first 48 to 72
hours. This happens with no change to the power setting driving the piston. As
demonstrated by this study; as lung compliance improves, tidal volume will increase and
amplitude will decrease with no change in the power setting. Extrapolating upon this
data, if the clinician were to increase the power to the piston to achieve the original
amplitude the tidal volume delivered from the ventilator will increase. This will be
detrimental to the patient for two clinical reasons. First, the current treatment of ARDS is
low tidal volume, high PEEP and lower alveolar pressures. If adequate volume can be
maintained at lower ventilating pressures; there is no reason for a clinician to potentially
cause further pulmonary barotrauma by increasing the volume delivered by increasing the
power setting to achieve the original amplitude. Secondly, because the patient’s lung is
non-compliant, increasing the power (amplitude) and correspondingly the tidal volume,
the clinician puts the patient at risk for developing a pneumothorax. Even though it
appears to be an insignificant increase in Vt 14 mL from the least compliant to the most
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compliant this number is equivalent to a minute volume of 5.2 L which is a significant
increase and could potentially be detrimental to the patient.
There are limitations to the generalizations of this study. It was a bench study and
this may not be what happens physiologically to the patient but the results are believed to
be reflective of what happens in clinical practice. The gas delivered to the ASL 5000 was
not heated or humidified, as recommended by the manufacturer to prevent damage to the
ASL 5000. This is not reflective of what happens in clinical practice. In clinical
practice, any time a patient is placed on HFOV the gas being delivered to the patient will
be heated and humidified. The number of trials was small in number but sufficient to
support what happens in clinical practice. In clinical practice, amplitude will decrease as
lung compliance improves and as reflected by this bench study, amplitude did decrease
spontaneously with improving compliance. This resulted in an increase in delivered tidal
volume. The fact that this bench study does not necessarily reflects what happens to a
patient on HFOV makes this a shortcoming.
A question that has also frustrated clinicians is: Many patients who are placed on
HFOV are refractory to oxygenation and in attempt to reverse this condition iNO is
initiated shortly after HFOV with little or no success. But if iNO were to be reinstated 24
to 48 hours later will there be an improvement in oxygenation? For iNO to be effective it
must travel through the alveolus into the vasculature causing smooth muscle relaxation
and arteriolar dilation (INOmax). As demonstrated by this study, as compliance of the
lung improves, as seen by a decrease in amplitude and an increase in tidal volume, does
this then reflect an increase in the functional residual capacity of the patient allowing
more alveolar surface area for iNO to travel into the vasculature? In clinical practice iNO
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is used in the premature infant for refractory hypoxemia. Institutions that use iNO in their
NICUs also use iNO with their adult patients and found an increase in the reversal of
hypoxemia and pulmonary hypertension. Building upon these clinical observations, iNO
has made its way into the adult ICU even though it is considered off label in many
instances. To build upon this study a follow up survey of users of HFOV and their
success in reversing refractory hypoxemia using iNO and HFOV versus conventional
ventilation should be investigated.
The use of HFOV in the treatment of ARDS is still considered by many to be a
rescue modality. It is incumbent upon us as respiratory therapists to inform the medical
community that the early use of HFOV may be helpful to the patient. The use of HFOV
allows the respiratory therapist to deliver smaller tidal volumes at lower pressure and still
maintain adequate alveolar ventilation. HFOV is not a modality stressed in the medical
or clinical education of current critical care physicians. With proper training of critical
care respiratory therapists and nurses it can become another adjunct in the treatment of
this disease. Early intervention with HFOV has been shown to help in the treatment of
ARDS but until the medical community is comfortable with this modality it will remain
as a rescue device only.
To conclude, this study showed; there is an indirect correlation with AMP and Vt.
As compliance improves the tidal volume, delivered to a patient on HFOV will increase
and the AMP will decrease.

Definitions
Premarket Approval (PMA) - any premarket approval application for a class III medical
device, including all information submitted with or incorporated by reference. "PMA"
includes a new drug application for a device under section 520(l) of the FD&C Act.

Functional Residual Capacity (FRC) - this is the lung volume at the end of a normal
expiration, when the muscles of respiration are completely relaxed
Lung compliance - the ease in which a structure distends. Mathematically lung
compliance is volume change divided by pressure change. Normal lung compliance of
the lung is 0.1 L/cmH2O.
Tidal Volume – the amount of air inspired and expired during one normal breath.
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APPENDIX
Appendix A
Protocol
High-Frequency & Tidal Volume
Goals:
•

To determine the delivered Vt at a predetermined lung compliance

•

To examine the influence of lung compliance on the delivered Vt (n=5 for
each compliance)

Methods:
•

For lung compliance 10 mL/cm H2O do five trials as follow;
A) Test lung
1. Use ASL 5000 breathing simulator.
2. Connect the simulator ASL 5000 to line power then switch it on.
i. The Motor red light is enabled.
ii. Wait for the Motor red light to turn off.
iii. ASL 5000 is calibrated and ready to be connected to the
ventilator and computer.
3. Connect the ASL 5000 to the host PC via Ethernet networking cable.
4. Connect the ASL 5000 with HFOV through standard high-frequency
breathing circuit and size 8.0 mm I.D. cuffed ETT.
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B) Ventilator
1. Use SensorMedics 3100B
2. Calibrate the 3100B ventilator with capped standard high-frequency
breathing circuit;
i. Set bias flow at 30 L/min.
ii. Mean Airway Pressure (mPaw) to maximum.
iii. Pressure amplitude (delta-P) of 60 cm H2O.
iv. Set inspiratory time (I-time) to 33%.
v. Start the 3100B ventilator wait for the mPaw reading to
reach between 40 & 45 cm H2O.
3. Set the 3100B ventilator to the following;
i. Set power to 6.0; pressure amplitude reading will be variable.
ii. Frequency (f) of 5 Hz.
iii. Mean Airway Pressure will be variable.
iv. Set bias flow at 30 L/min.
v. I-time to 33%.
vi. Oxygen to 50%.
4. Connect the standard high-frequency breathing circuit and size 8.0 mm
I.D. cuffed ETT (Portex, Hythe Kent, England) to the ASL 5000.
5. Go to step (c – 9 – i).
C) Computer
1. After all necessary cable connections have been completed (step a – 3);
launch the LabView software on the host PC.
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2. Working page (welcome window) is presented;
i. From welcome window choose run the software with Ethernet
mode.
ii. Welcome window will disappear and several windows will be
stacking up on computer screen.
iii. Host computer will attempt to synchronize with the ASL 5000.
iv. Wait for ASL 5000 response (simulator piston will move).
3. From the Script Editor window chose (Adult_apnea.sct) file to
edit its model parameter files.
4. From the Script File‖ box click two times on the file name
(Adult_apnea.sct).
5. A window titled "Step 1: Select Simulation Parameter Set" will open.
i. Click edit to proceed to the next step.
6. A window titled step 2: choose a lung model‖ will open.
i. Chose the two compartment lung model.
ii. Set resistance (Raw1) to 15 cm H2O/L/sec.
iii. Set resistance (Raw2) to 15 cm H2O/L/sec.
iv. Set compliance (CL1) to10 mL/cm H2O.
v. Set compliance (CL2) to 10 mL/cm H2O.
vi. Click next.

29
7. A window titled Step 3: Chest Wall Model‖ will open.
i. From chest wall model pop-up menu chose passive model.
ii. Set the passive cycle to 12 breathes per minute.
iii. Click next.
8. A window titled step 4: save simulation parameter set will open.
i. Click save, to save the new variables in the file.

9. From the Central Runtime Window while the ventilator is running and
connected to the ASL 5000
i. Start the simulation by moving the "slide switch from the off to
the on position.
ii. From file window chose a name for the data file path to store the
data.
iii. Click OK.
10. Go to Breath Detection / Real-Time Analysis window.
i. Check the save data to high resolution file checkbox.
ii. Wait for the data of 250 breaths to be collected.
11. Turn off the simulation by moving the "slide switch from the on to
the off position.
D) Data Collection
1. Launch the Lab VIEW software on the host computer.
2. Go to post-run window.
i. Choose the file to be displayed click it two times.
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ii. Open multiple parameter trend from the green box under the
display data list.
3. Check the Vt waveform to establish the steady state.
i. The Vt increases gradually to build up the volume in the test
lung
ii. The steady state is when there is no more increase in the Vt
delivered
4. Review the volume waveform
5. Record the tidal volume and use it in data analysis.
•

For the compliance of 15, 20,and 25 mL/cm H2O do five trials as follow:
1. Repeat steps 9 and 10
2. Record data as explained in letter D

Appendix B: Raw data from trials:

Comp

Comp
Comp

ml/cmH2O AMP

Vt

Comp
AMP

Vt ml/cmH2O

ml/cmH2O

Vt
AMP

AMP

Vt

ml/cmH2O

10

88 118.31

15

86 121.93

20

84 123.58

25

82 131.93

10

88 116.36

15

86 123.42

20

84 123.79

25

82 132.02

10

87 118.87

15

86 121.02

20

84 126.99

25

82 132.85

10

87 117.36

15

86 119.64

20

84 125.77

25

82 131.68

10

87 117.29

15

86 122.62

20

84 126.08

25

82 132.11
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